Advances in the Treatment of HIV: Focus on Newer Strategies

In this presentation, Dr. Andrew Zolopa, Professor Emeritus of Medicine at Stanford School of Medicine, discusses the history of antiretroviral therapy (ART) in HIV-infected patients. He highlights some of the potential long-term risks of ART regimens in this patient population. Dr. Zolopa describes the recent advances in the treatment of HIV-infected patients, such as two-drug regimens which have been included in clinical guidelines, and long-acting injectable drugs that are being evaluated in clinical trials.

In the second part of his presentation, Dr. Zolopa examines the different strategies and challenges of treating viral suppressed HIV-infected patients versus treatment-naïve patients. 

Target Audience

This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Review the history of antiretroviral therapy (ART) development, highlighting successes and challenges.

  • Discuss the risk of long-term toxicities in patients treated with ART.

  • Analyze the latest advances in the treatment of HIV-infected patients with a focus on newer strategies for managing those patients over the long term.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/01/2019
Course expires: 
08/31/2021
Rating: 
0

Richard J. Hamill, M.D., Planning Committee Member 
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Erica Lescinskas, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Zaven Sargsyan, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Chirayu Shah, M.D., M.Ed., Planning Committee Member
Associate Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Stephanie Sherman, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Jefferson Triozzi, M.D., Planning Committee Member
Internal Medicine Resident
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.